The category of compounds referred to as β-1,4-Gal-T5 Activators includes chemicals that may indirectly influence the activity or expression of β-1,4-Gal-T5, an enzyme integral to the glycosylation of proteins. Beta-1,4-Galactosyltransferase 5 s an enzyme that specializes in the biosynthesis of glycoconjugates by transferring galactose from a donor substrate, such as uridine diphosphate galactose (UDP-galactose), to acceptor molecules like N-acetylglucosamine (GlcNAc) on glycoproteins and glycolipids. The class of chemicals known as β-1,4-Gal-T5 activators encompasses the compounds that can enhance the enzymatic function of β-1,4-Gal-T5, which is to facilitate the formation of β-1,4-glycosidic bonds.
These activators may function directly by binding to the enzyme and inducing a conformational change that increases its catalytic efficiency. This could involve allosteric modulation where the activator binds to a site distinct from the active site, eliciting an effect that enhances the enzyme's ability to bind to its substrates or to release its products more effectively. Alternatively, direct activators could interact with the active site itself, stabilizing the enzyme-substrate complex and promoting a more favorable reaction environment for the transfer of the galactose moiety. Indirect activators of β-1,4-Gal-T5 can operate through various mechanisms, such as upregulating the expression of the gene coding for this enzyme, thereby increasing its abundance in the cell. They might also influence the levels of substrates available for the galactosylation process, for instance, by increasing the cellular pool of UDP-galactose or by modulating the levels of transporter proteins that facilitate the entry of this donor substrate into the Golgi apparatus where β-1,4-Gal-T5 is localized.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cyclic AMP levels, which can stimulate protein glycosylation processes and potentially indirectly increase β-1,4-Gal-T5 activity. | ||||||
Thiamet G | 1009816-48-1 | sc-224307 sc-224307A | 1 mg 5 mg | $52.00 $96.00 | 1 | |
Thiamet G inhibits O-GlcNAcase, which can increase the overall level of O-GlcNAc modified proteins and potentially indirectly increase β-1,4-Gal-T5 activity due to increased substrate availability. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Glucosamine serves as a substrate for glycosylation processes, potentially enhancing the activity of β-1,4-Gal-T5 indirectly. | ||||||
D-Mannose | 3458-28-4 | sc-211180 sc-211180A | 100 g 250 g | $103.00 $161.00 | 1 | |
Mannose is a substrate for glycosylation, potentially enhancing the activity of β-1,4-Gal-T5 indirectly. | ||||||
Uridine | 58-96-8 | sc-296685 sc-296685A | 1 g 25 g | $61.00 $100.00 | 1 | |
Uridine is a component of UDP-sugar donors, the substrates for β-1,4-Gal-T5, potentially enhancing its activity indirectly. | ||||||
Deoxymannojirimycin hydrochloride | 84444-90-6 | sc-201360 sc-201360A | 1 mg 5 mg | $93.00 $239.00 | 2 | |
Deoxymannojirimycin inhibits mannosidase, potentially affecting β-1,4-Gal-T5 activity indirectly. | ||||||